The decision of some Indonesians to obtain health services abroad has its own economic impact on the domestic economy. President Joko Widodo revealed that Indonesia loses around Rp. 97 trillion every year due to decisions made by its citizens to seek treatment abroad.
“Because we know that every year there are approximately two million of our people who go abroad to get health (services), be it Singapore, Malaysia, Japan, the United States and other places. And we lost IDR 97 trillion because of that,” said Jokowi at the Bali International Hospital Groundbreaking event, in the Sanur area, Bali, Monday (27/12).
Seeing this fact, the government through the Ministry of SOEs is trying to answer the challenges that arise by initiating the construction of the Bali International Hospital (RS) in order to create the first special health economic zone (SEZ) in the country, with the hope that no more Indonesian people will seek treatment abroad. .
“Bali will become a health tourism destination and this will increase people’s tourism to Bali. And we hope that it is not our people who go out, but outsiders who will later enter Indonesia to get health services because here there is a collaboration between us and the Mayo Clinic from the United States,” he said.
This international standard hospital is targeted to be operational in mid-2023. In addition to the hospital, Jokowi also hopes that Indonesia can have independence in producing medical devices, raw materials for drugs and vaccines, so that imports to support the health system in this country can be significantly suppressed.
“Not only hospitals, but also medicines, raw materials, we don’t want to import again, medical devices, medicines, medicinal raw materials, we have to stop importing these items again and do it ourselves, produce them in our own country. us,” he said.
Health System Independence
On the same occasion, SOE Minister Erick Thohir said the presence of the Bali International Hospital was expected to help Bali to diversify its economy with health tourism. As is known, the Balinese economy, which relies heavily on the tourism sector, has been shaken by travel restrictions related to COVID-19.
“This also supports the Minister of Investment, the Minister of Trade, the Minister of Industry and the Coordinating Minister, because investment means that they want to ensure their health is guaranteed, international health standards for their workers or professionals in Indonesia, because that’s why this platform is very important for us. wake up in Bali,” said Erick.
He then explained that the state-owned pharmaceutical company Bio Farma as the holding company in charge of Kimia Farma, Indo Farma and the existing state-owned hospitals will start building an ecosystem to support the Indonesian health system, by producing raw materials for drugs and vaccines in their own country.
On the same occasion, Erick said that Bio Farma had started clinical trials of the COVID-19 vaccine on December 13 last. If the clinical trial is successful, he said, Bio Farma is ready to produce up to 77 million doses of vaccine next year.
In addition, Indo Farma, said Erick, is prepared to develop the herbal industry for medicinal raw materials. According to him, this herbal industry can grow rapidly considering the potential of herbal raw materials and culture in Indonesia itself which is quite high for these herbal ingredients.
Meanwhile for Kimia Farma itself, Erick explained that the company will focus on producing generic drugs, so that public access to cheap drugs will expand.
“If this is combined, we hope that in the next four years we can reduce imports of medicinal raw materials by 75 percent from the original 95 percent,” he concluded. [gi/rs]